Cisplatin, Fluorouracil in Bolus Injection, and Leucovorin in First-Line Therapy for Advanced Gastric Cancer as an Alternative to Protocols With Infusional Fluorouracil

Cisplatin, Fluorouracil in Bolus Injection, and Leucovorin in First-Line Therapy for Advanced Gastric Cancer as an Alternative to Protocols With Infusional Fluorouracil

PURPOSE: Gastric cancer (GC) is the fourth most common cancer and the second leading cause of cancer death worldwide. Platinum agents and fluoropyrimidines are the main compounds used in the first-line setting for advanced GC. Given the activity of fluorouracil (FU) bolus, the PFL protocol, a chemot...

Full description

Bibliographic Details
Main Authors: Rafael C. Coelho, Pedro D.P. Abreu, Mariana R. Monteiro, Ana Paula Stramosk, Alvaro Henrique I. Garces, Andreia Cristina Melo, Marcia S. Graudenz, Carlos Jose C. Andrade
Format: Article
Language:English
Published: American Society of Clinical Oncology 2019-01-01
Series:Journal of Global Oncology
Online Access:http://ascopubs.org/doi/10.1200/JGO.18.00176

Similar Items

Similar Items